Evidence map›Paper›PMID 28591853›Full record

ReviewPathogens and disease2017

Neisseria genomics: current status and future perspectives.

Odile B Harrison, Christoph Schoen, Adam C Retchless, Xin Wang, Keith A Jolley, James E Bray, Martin C J Maiden

Abstract readReview
In one paragraph

Review in Pathogens and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Trial
  2. Management and prevention of Neisseria meningitidis and Neisseria gonorrhoeae infections in the context of evolving antimicrobial resistance trends.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  3. Article
  4. Whole Genome Analyses Accurately IdentifyInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Use of Andromas and Bruker MALDI-TOF MS in the identification of Neisseria.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2018
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Odile B HarrisonDepartment of Zoology, University of Oxford, Oxford OX1 3SY, UK.
Christoph SchoenInstitute for Hygiene and Microbiology, University of Würzburg, Würzburg 97080, Germany.
Adam C RetchlessCenters for Disease Control and Prevention, Atlanta, GA 30333, USA.
Xin WangCenters for Disease Control and Prevention, Atlanta, GA 30333, USA.
Keith A JolleyDepartment of Zoology, University of Oxford, Oxford OX1 3SY, UK.
James E BrayDepartment of Zoology, University of Oxford, Oxford OX1 3SY, UK.
Martin C J MaidenDepartment of Zoology, University of Oxford, Oxford OX1 3SY, UK.

Funding

Wellcome TrustWellcome Trust 087622/Z/08/2Wellcome Trust 104992
6 · The paper itself

Abstract

High-throughput whole genome sequencing has unlocked a multitude of possibilities enabling members of the Neisseria genus to be examined with unprecedented detail, including the human pathogens Neisseria meningitidis and Neisseria gonorrhoeae. To maximise the potential benefit of this for public health, it is becoming increasingly important to ensure that this plethora of data are adequately stored, disseminated and made readily accessible. Investigations facilitating cross-species comparisons as well as the analysis of global datasets will allow differences among and within species and across geographic locations and different times to be identified, improving our understanding of the distinct phenotypes observed. Recent advances in high-throughput platforms that measure the transcriptome, proteome and/or epigenome are also becoming increasingly employed to explore the complexities of Neisseria biology. An integrated approach to the analysis of these is essential to fully understand the impact these may have in the Neisseria genus. This article reviews the current status of some of the tools available for next generation sequence analysis at the dawn of the 'post-genomic' era.

Indexed as

Genome, BacterialAnti-Bacterial AgentsDatabases, GeneticDatasets as TopicDNA, BacterialDrug Resistance, BacterialGenomicsGonorrheaHigh-Throughput Nucleotide SequencingHumansMeningitis, MeningococcalNeisseria gonorrhoeaeNeisseria meningitidisTranscriptomeVirulenceWhole Genome SequencingAnti-Bacterial AgentsDNA, BacterialNeisseria gonorrhoeae; Omics analysesNeisseria meningitidisnext-generation sequencing

Identifiers

PMID28591853
PMCPMC5827584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.